Exchange Bulletin
Cannara Biotech Inc. (LOVE) To Trade On Toronto Stock Exchange
March 2, 2026
| Issuer: | Cannara Biotech Inc. (the "Company") |
| Security: | Common shares (the "Common Shares") |
| Symbol: | LOVE |
| Number of securities issued and outstanding: | 98,782,148 Common Shares |
| Number of securities reserved for issuance: | 14,817,322 Common Shares |
| Trading currency: | CDN$ |
| Listing and posted for trading date: | March 2, 2026 (at the opening) |
| Listing category: | Diversified Companies |
| Other market(s): | The Common Shares have been listed on TSX Venture Exchange since April 8, 2021 under the symbol "LOVE". The Common Shares will be delisted from TSX Venture Exchange on March 2, 2026, upon commencement of trading on Toronto Stock Exchange. |
| Temporary market maker: | Independent Trading Group (ITG) Inc. |
| Investor relations: | Mr. Nicholas Sosiak (514) 543-4200, ext. 254 Email: nicholas.sosiak@cannara.ca Mr. Scott Carroll (514) 830-7325 Email: scott.carroll@cannara.ca |
| Incorporation: | The Company was incorporated under the Business Corporations Act (British Columbia) on October 19, 2017. |
| Fiscal year end: | August 31 |
| Nature of business: | The Company is a vertically integrated producer of cannabis and cannabis-derivative products for the Canadian markets. |
| Transfer agent and registrar: | Computershare Investor Services Inc. at its principal offices in Toronto and Vancouver |
| Dividends: | The Company has not paid dividends in the past and does not anticipate paying dividends in the near future. |
| Sponsorship: | Not applicable |
| Disclosure document: | Annual Information Form dated November 24, 2025 which is available at www.sedarplus.ca. Capitalized terms not otherwise defined herein are as defined in the disclosure document. |
| TSX contact: | Anne Child, Managing Director, TSX Listings |